You've just added:

Checkout Go to Cart
Home / News

News + Media

September 10, 2025

Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025

OXFORD, UK and CLEVELAND, Ohio, US, 10 September 2025 – The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, dedicated to creating new medicines for rare diseases, announces that Lord...

Continue Reading

July 09, 2025

Breakthrough Treatment Helps Child Walk Again After Rare Brain Disease Diagnosis

Experimental Compound Offers Potential Treatment for Rare, Often Fatal, Childhood Disease Continue Reading

June 24, 2025

Nominations Open for 13th Annual International Harrington Prize for Innovation in Medicine

Harrington Discovery Institute and the American Society for Clinical Investigation seek nominations to recognize an outstanding achievement by a physician-scientist Continue Reading

June 04, 2025

David Cameron: DNA test all sick children to build register

The former prime minister has called for children admitted to paediatric care to undergo genome sequencing as part of a drive to cure 40 rare diseases Continue Reading

June 03, 2025

Harrington Discovery Institute Announces 2025 Scholar-Innovator Award Recipients

Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic Continue Reading

May 23, 2025

Former British Prime Minister David Cameron, Medical Leaders and Researchers from around the World Convene in Cleveland to Discuss Drug Development Progress

Scientific researchers and leaders from across the globe gathered in Cleveland, Ohio to discuss progress being made in drug development for a variety of conditions, including Alzheimer’s and rare diseases. Continue Reading

May 21, 2025

Inhibiting 15-PGDH blocks blood–brain barrier deterioration and protects mice from Alzheimer’s disease and traumatic brain injury

Alzheimer’s disease (AD) and traumatic brain injury (TBI) are currently untreatable neurodegenerative disorders afflicting millions of people worldwide. These conditions are pathologically related, and TBI is one of the greatest risk factors for AD. Continue Reading

May 01, 2025

Alzheimer’s Drug Discovery Foundation and Harrington Discovery Institute Brain Health Medicines Center Invite Proposals for the 2026 ADDF-Harrington Scholar Award

Call for proposals on proteostasis and senescence are particularly encouraged, alongside all novel approaches to treating Alzheimer’s disease Continue Reading

April 29, 2025

Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council

Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation Continue Reading

April 16, 2025

Harrington Discovery Institute Opens Call for 2026 Harrington Scholar-Innovator Award

Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading

March 19, 2025

International Harrington Prize Awarded to Dr. Owen Witte

2025 Harrington Prize for Innovation in Medicine recognizes groundbreaking contributions in the creation of targeted cancer therapies Continue Reading

We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.